List of Tables
Table 1. Global Spinal Muscular Atrophy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Early Stage Candidates
Table 3. Key Players of Late Stage Candidates
Table 4. Global Spinal Muscular Atrophy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Spinal Muscular Atrophy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Spinal Muscular Atrophy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Spinal Muscular Atrophy Market Share by Region (2018-2023)
Table 8. Global Spinal Muscular Atrophy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Spinal Muscular Atrophy Market Share by Region (2024-2029)
Table 10. Spinal Muscular Atrophy Market Trends
Table 11. Spinal Muscular Atrophy Market Drivers
Table 12. Spinal Muscular Atrophy Market Challenges
Table 13. Spinal Muscular Atrophy Market Restraints
Table 14. Global Spinal Muscular Atrophy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Spinal Muscular Atrophy Revenue Share by Players (2018-2023)
Table 16. Global Top Spinal Muscular Atrophy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy as of 2022)
Table 17. Global Spinal Muscular Atrophy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Spinal Muscular Atrophy, Headquarters and Area Served
Table 20. Global Key Players of Spinal Muscular Atrophy, Product and Application
Table 21. Global Key Players of Spinal Muscular Atrophy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Spinal Muscular Atrophy Revenue Market Share by Type (2018-2023)
Table 25. Global Spinal Muscular Atrophy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Spinal Muscular Atrophy Revenue Market Share by Type (2024-2029)
Table 27. Global Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy Revenue Share by Application (2018-2023)
Table 29. Global Spinal Muscular Atrophy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Spinal Muscular Atrophy Revenue Share by Application (2024-2029)
Table 31. North America Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Spinal Muscular Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Spinal Muscular Atrophy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Spinal Muscular Atrophy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Spinal Muscular Atrophy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Spinal Muscular Atrophy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Spinal Muscular Atrophy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Spinal Muscular Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Country (2024-2029) & (US$ Million)
Table 63. Lonis Pharmaceuticals Company Details
Table 64. Lonis Pharmaceuticals Business Overview
Table 65. Lonis Pharmaceuticals Spinal Muscular Atrophy Product
Table 66. Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 67. Lonis Pharmaceuticals Recent Developments
Table 68. F. Hoffmann-La Roche Company Details
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Spinal Muscular Atrophy Product
Table 71. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 72. F. Hoffmann-La Roche Recent Developments
Table 73. AveXis Company Details
Table 74. AveXis Business Overview
Table 75. AveXis Spinal Muscular Atrophy Product
Table 76. AveXis Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 77. AveXis Recent Developments
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Spinal Muscular Atrophy Product
Table 81. Novartis Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 82. Novartis Recent Developments
Table 83. Cytokinetics Company Details
Table 84. Cytokinetics Business Overview
Table 85. Cytokinetics Spinal Muscular Atrophy Product
Table 86. Cytokinetics Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 87. Cytokinetics Recent Developments
Table 88. Ionis Pharmaceuticals Company Details
Table 89. Ionis Pharmaceuticals Business Overview
Table 90. Ionis Pharmaceuticals Spinal Muscular Atrophy Product
Table 91. Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 92. Ionis Pharmaceuticals Recent Developments
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Spinal Muscular Atrophy Market Share by Type: 2022 VS 2029
Figure 3. Early Stage Candidates Features
Figure 4. Late Stage Candidates Features
Figure 5. Global Spinal Muscular Atrophy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Spinal Muscular Atrophy Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Spinal Muscular Atrophy Report Years Considered
Figure 11. Global Spinal Muscular Atrophy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Spinal Muscular Atrophy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Spinal Muscular Atrophy Market Share by Region: 2022 VS 2029
Figure 14. Global Spinal Muscular Atrophy Market Share by Players in 2022
Figure 15. Global Top Spinal Muscular Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Revenue in 2022
Figure 17. North America Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Spinal Muscular Atrophy Market Share by Type (2018-2029)
Figure 19. North America Spinal Muscular Atrophy Market Share by Application (2018-2029)
Figure 20. North America Spinal Muscular Atrophy Market Share by Country (2018-2029)
Figure 21. United States Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Spinal Muscular Atrophy Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Spinal Muscular Atrophy Market Share by Type (2018-2029)
Figure 25. Europe Spinal Muscular Atrophy Market Share by Application (2018-2029)
Figure 26. Europe Spinal Muscular Atrophy Market Share by Country (2018-2029)
Figure 27. Germany Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Spinal Muscular Atrophy Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Spinal Muscular Atrophy Market Share by Type (2018-2029)
Figure 35. China Spinal Muscular Atrophy Market Share by Application (2018-2029)
Figure 36. Asia Spinal Muscular Atrophy Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Spinal Muscular Atrophy Market Share by Type (2018-2029)
Figure 38. Asia Spinal Muscular Atrophy Market Share by Application (2018-2029)
Figure 39. Asia Spinal Muscular Atrophy Market Share by Region (2018-2029)
Figure 40. Japan Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Share by Country (2018-2029)
Figure 50. Brazil Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 58. AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 59. Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 60. Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 61. Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed